NOV
52
-5
D
40
2
STZ
52
-6
ROST
57
-3
SYY
49
9
MUR
44
-3
AIZ
82
2
DE
42
3
ESS
62
-3
EXPD
43
-4
BBY
52
6
GM
74
5
MSFT
48
-9
TEL
60
-8
HAL
48
-3
CL
54
3
CFG
74
2
STX
45
-4
AON
54
2
VRSK
68
-12
NOV
52
-5
D
40
2
STZ
52
-6
ROST
57
-3
SYY
49
9
MUR
44
-3
AIZ
82
2
DE
42
3
ESS
62
-3
EXPD
43
-4
BBY
52
6
GM
74
5
MSFT
48
-9
TEL
60
-8
HAL
48
-3
CL
54
3
CFG
74
2
STX
45
-4
AON
54
2
VRSK
68
-12
Financhill
Back

Global X S&P 500® Collar 95-110 ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
95

XCLR
Global X S&P 500® Collar 95-110 ETF

Last Price:
32.58
Seasonality Move:
1.67%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
95
Global X S&P 500® Collar 95-110 ETF (XCLR) is a Buy

Is Global X S&P 500® Collar 95-110 ETF a Buy, Sell or Hold?

  • The current Global X S&P 500® Collar 95-110 ETF [XCLR] share price is $32.62. The Score for XCLR is 95, which is 90% above its historic median score of 50, and infers lower risk than normal.
  • XCLR is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XCLR Stock Price Chart

What is Global X S&P 500® Collar 95-110 ETF's stock price today?

  • The Global X S&P 500® Collar 95-110 ETF share price today is $32.62
    The current trend is moderately bearish and XCLR is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

XCLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 51.31 Buy
Chaikin Money Flow: -281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.22 - 32.96) Buy
Bollinger Bands (100): (30.75 - 32.39) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

XCLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.04 Sell
20-day SMA: 32.6 Buy
50-day SMA: 32.2 Buy
200-day SMA: 30.47 Buy
8-day EMA: 32.87 Sell
20-day EMA: 32.67 Sell
50-day EMA: 32.23 Buy
200-day EMA: 30.47 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Global X S&P 500® Collar 95-110 ETF Earnings Growth & XCLR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Global X S&P 500® Collar 95-110 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):